Agree Realty guides for $1.1B-$1.3B of investment volume in 2025
Agree Realty guides for $1.1B-$1.3B of investment volume in 2025
J&J completes $2B acquisition of ADC developer Ambrx
Johnson & Johnson to acquire ADC developer Ambrx Biopharma for $2B
8.42BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US0084921008
CUSIP
008492100
Sector
Real Estate
Industry
REIT - Retail
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
42.70
PEG Ratio
-28.74
Book Value
49.81
Dividend Share
3.018
Dividend Yield
4.06%
Earnings Share
1.79
Wall Street Target Price
81.73
EPS Estimate Current Year
1.71
EPS Estimate Next Year
1.84
EPS Estimate Current Quarter
0.4251
EPS Estimate Next Quarter
0.417
Most Recent Quarter
-
Revenue TTM
636,801,984
Gross Profit TTM
560,062,976
EBITDA
552,777,024
Profit Margin
30.05%
Return On Assets TTM
2.30%
Return On Equity TTM
3.55%
Revenue Per Share TTM
6.195
Qtly Revenue Growth YOY
13.20%
Diluted Eps TTM
1.79
Qtly Earnings Growth YOY
-1.80%
Trailing PE
42.70
Forward PE
44
Price Sales TTM
13.2221
Price Book MRQ
1.5374
Enterprise Value Revenue
18
Enterprise Value EBITDA
20
1.75
7.36%4.75
3.04%20.89
0.69%57.33
0.14%71.88
0.10%33.99
0.00%2.25
0.00%83.17
0.00%20.08
-1.98%156.80
-1.06%